Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

• Hauptverfasser: Emin Abdullayev (Verfasst von), Omer Kilic (Verfasst von), Gurkan Bozan (Verfasst von), Eylem Kiral (Verfasst von), Merve Iseri Nepesov (Verfasst von), Ener Cagri Dinleyici (Verfasst von)
• Format: Buch
• Veröffentlicht: Taylor & Francis Group, 2020-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Introduction Although there are studies about sepsis treatment in different age groups, data on immunoglobulin-M (IgM)-enriched intravenous immunoglobulin use in pediatric intensive care units (PICUs) are limited. The aim of this study was to evaluate the clinical features and prognoses of children...